For laboratory research use only. This page summarises published scientific literature on GHRP-6 in plain English, in a neutral research style. It is not medical advice and contains no guidance on doses, administration or human use.
GHRP-6 (Growth Hormone Releasing Peptide-6) is one of the most extensively studied growth hormone secretagogues in peptide research. As a synthetic hexapeptide, it mimics the action of ghrelin to stimulate natural growth hormone (GH) release from the pituitary gland. This guide consolidates the current research landscape, UK legal framework, safety data, and practical considerations for GHRP-6.
What Is GHRP-6?
GHRP-6 is a synthetic hexapeptide (six amino acids: His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂) first characterised in the 1980s. It belongs to the growth hormone secretagogue (GHS) family and acts primarily as a ghrelin receptor (GHSR-1a) agonist. Unlike GHRH (Growth Hormone Releasing Hormone), which only amplifies GH pulses, GHRP-6 both triggers and amplifies GH release, making it a potent dual-action secretagogue.
Key distinguishing features of GHRP-6 include its strong hunger-stimulating effect (a consequence of ghrelin receptor activation), its ability to markedly elevate GH through a mechanism independent of GHRH, and a well-characterised research profile spanning several decades.
Mechanism of Action
Ghrelin Receptor Agonism
GHRP-6 binds with high affinity to the growth hormone secretagogue receptor type 1a (GHSR-1a), the same receptor activated by the endogenous hunger hormone ghrelin. GHSR-1a receptors are densely expressed in the hypothalamus and pituitary gland. Upon binding, GHRP-6 triggers a cascade involving Gq-protein signalling, phospholipase C activation, and ultimately a sharp rise in intracellular calcium within somatotroph cells — the pituitary cells that synthesise and release GH.
Hypothalamic Amplification
Beyond direct pituitary action, GHRP-6 also acts at the hypothalamus to stimulate GHRH release and suppress somatostatin (the endogenous GH-inhibiting hormone). This dual hypothalamic effect is part of why GHRP-6 produces larger GH pulses than GHRH alone. Research combining GHRP-6 with exogenous GHRH (or a GHRH analogue such as CJC-1295) demonstrates synergistic, supraphysiological GH release — a combination widely studied in research settings.
IGF-1 Downstream Effects
The GH pulses triggered by GHRP-6 stimulate hepatic IGF-1 (Insulin-like Growth Factor-1) synthesis. IGF-1 mediates many of the anabolic, tissue-repair, and metabolic effects associated with elevated GH. Elevated IGF-1 promotes protein synthesis, inhibits protein breakdown, enhances glucose uptake into muscle, and stimulates collagen production in connective tissues.
GHRP-6 vs. Other Growth Hormone Secretagogues
| Peptide | Receptor Target | GH Pulse Strength | Hunger Effect | Research Depth |
|---|---|---|---|---|
| GHRP-6 | GHSR-1a | Strong | Strong (ghrelin-like) | Extensive (3+ decades) |
| GHRP-2 | GHSR-1a | Very Strong | Moderate | Extensive |
| Ipamorelin | GHSR-1a | Moderate | Minimal | Moderate |
| Hexarelin | GHSR-1a | Very Strong | Minimal | Moderate |
| MK-677 (Ibutamoren) | GHSR-1a (oral) | Strong (sustained) | Strong | Moderate |
| CJC-1295 | GHRH receptor | Moderate (sustained) | None | Moderate |
Research Findings
Hepatoprotection and Fibrosis Reduction
GHRP-6 has demonstrated hepatoprotective properties in several rodent models of liver injury. Studies in models of non-alcoholic steatohepatitis (NASH), chemical-induced hepatotoxicity, and bile duct ligation have shown that GHRP-6 reduces markers of hepatic inflammation (TNF-α, IL-6), attenuates fibrosis development (reduced TGF-β1 and collagen deposition), and supports hepatocyte survival. These findings have prompted interest in GHRP-6 as a research tool in hepatic fibrosis models.
Appetite and Metabolic Effects
GHRP-6’s agonism at GHSR-1a is associated with potent appetite stimulation. This is the same receptor through which ghrelin — the “hunger hormone” — drives appetite. In research settings, GHRP-6 consistently increases food intake in rodent models, and the hunger-stimulating effect is well-reported by researchers working with the peptide. Simultaneously, the GH elevation promoted by GHRP-6 supports lipolysis (fat breakdown), creating a complex metabolic environment that has been studied in the context of body composition research.
GHRP-6 Quality and Sourcing in the UK
Why Peptide Purity Matters
Peptide synthesis quality varies significantly across suppliers. Impurities in GHRP-6 research material can include truncated sequences (synthesis failures), oxidised methionine residues (where applicable), residual reagents from synthesis, and incorrectly folded peptide chains. These impurities affect biological activity, introduce unpredictable variables into research data, and may pose safety concerns in research models. Researchers should source GHRP-6 from suppliers providing:
- High-performance liquid chromatography (HPLC) purity certificates showing ≥98% purity
- Mass spectrometry (MS) confirmation of molecular weight and sequence identity
- Batch-specific Certificates of Analysis (CoA) from accredited third-party laboratories
Research Summary and Key Takeaways
GHRP-6 is a well-characterised, extensively studied growth hormone secretagogue with a research profile spanning over three decades. Its core mechanism — GHSR-1a agonism leading to pituitary GH release — is robustly established, and its downstream effects through the GH/IGF-1 axis are consistent with known GH biology. Beyond its GH-secretagogue activity, preclinical evidence supports cytoprotective, cardioprotective, hepatoprotective, and tissue-repair-promoting properties through mechanisms that extend beyond GH alone.
As a foundational compound in GHS research, GHRP-6 remains one of the most important reference compounds for investigators studying the GH secretory axis, tissue protection, and metabolic signalling.
🇬🇧 UK Research Peptides: PeptidesLab UK supplies COA-verified GHRP-6 for research and laboratory use. View UK stock →
Limits of the evidence
Published findings come from specific study designs, often in cell systems or animals, and do not transfer automatically to other settings. A paper about a molecule is not proof that any particular batch has a given biological effect. Purity data show what is in a vial; they do not show sterility, safety or suitability for any use outside the laboratory.
Laboratory handling
- Store lyophilised powder sealed, cold (−20 °C for long-term storage), dry and protected from light.
- Let vials reach room temperature before opening to limit condensation.
- Prepare solutions with suitable laboratory solvents and calibrated equipment, and label each with lot number, concentration and date.
- Split solutions into single-use aliquots and avoid repeated freeze–thaw cycles.
- Use the peptide calculator for concentration arithmetic (mg/mL).
For laboratory research use only. GHRP-6 sold by Peptides Lab UK is supplied strictly for in vitro laboratory research. It is not for human or veterinary use, and nothing on this page is medical advice or guidance on administration. UK purchasers are responsible for complying with all applicable legislation.
